She was seen at six monthly intervals and name changed from Jean to Frank. Suprapubic hair had developed at 3 years; when 5 years old a diagnosis of virilism was considered because of stature, hair and deep voice, and at 6 a laparotomy was carried out. Female genitalia were discovered. A portion of a right suprarenal gland was removed and the sex reverted to female. Cortisone was started at 10 years old in 1952. Since then facial and leg hair has diminished, the girl now has normal breast development and menstruates regularly. P.H. was first seen aged 6 years, because of his large penis and well developed pubic hair, and although 17-ketosteroids were increased to above the normal adult range, a diagnosis of precocious puberty was made. When first seen by me at 11 years 9 months he was a tall thick-set boy with large penis and marked hair development. A diagnosis of virilism 4 was confirmed and prednisone therapy begun. Now at 13i the epiphyses are already fusing, but otherwise he is well controlled. Reasons for treatment are to maintain growth and to allow spermatogenesis. K.S. (virilising and salt-losing) is now aged 9 years. There was doubt about her sex at birth. At 7 days she started to be listless, took feeds badly and vomited occasionally. Blood taken for electrolyte determinations showed a typical picture of adrenal insufficiency.
DOCA and salt were given. Urine was collected for 17-ketosteroid deterination and marked increases were found. Cortisone was not originally available so she was initially maintained on DOCA and salt. Subsequently cortisone or prednisone has been used. A daily oral dose is given. She is now in a satisfactory state of health, bone age being commensurate with true age and the virilism is not progressive. Although pregnanetriol was isolated from the urine of a case of adrenal hyperplasia in 1938, detailed knowledge of the nature of the disease is much more recent. In 1948 Wilkins showed that stimulation of the adrenals with exogenous corticotrophin did not result in the urinary excretion of additional "corticoids." Later it was shown that the plasma hydrocortisone did not increase after ACTH as it does in normal persons, and that patients with congenital adrenal hyperplasia (C.A.H.) excrete large amounts of C21 steroids with a methyl group at the 21 position. The amount of these in normal urine is quite small, a 21-0H being added to the steroid nucleus within the adrenal cells to give the dihydroxyacetone side chain found in hydrocortisone. Sixteen C21 deoxy-steroids have been identified in the urine in C.A.H., many being isomers of pregnanetriol, 17-hydroxypregnanolone and ll-ketopregnanetriol. The significance of these became clear from work on the biosynthesis of adrenal steroids. Perfusion of normal adrenals with a medium containing progesterone results in the production of hydrocortisone. This requires the introduction of hydroxyl groups at C atoms 11, 17, and 21. In vitro studies suggested that these proceed in a definite order, but observations on cases with C.A.H. suggest this sequence is not obligatory. Thus hydroxylation at C-I I does not occur when the perfusate contains a 21 deoxysteroid; the existence of large amounts of C-I I ketonic material in C.A.H. shows that this process can take place in vivo. It was suggested that in C.A.H. a deficiency of the C-21 hydroxylating enzyme was the primary lesion; inability to complete synthesis of hydrocortisone would then lead to a lowered plasma level and a secondary increase in ACTH release from the anterior pituitary. Intense biosynthetic activity in the adrenal cortex then leads to the release of incompletely synthesized hydrocortisone (I7-hydroxyprogesterone; I I, 17dihydroxyprogesterone).
Subsequent metabolism of these in extra-adrenal tissues follows the usual pattern yielding pregnanetriol, 17hydroxypregnanolone and their l l-ketoanalogues. As these are hydroxylated at C-I 7, 17-ketosteroids are also formed being 11oxygenated or l l-deoxygenated according to the structure of the parent C-2l compound. Findings in C.A.H. are in general agreement with this though the chromatographic isolation of urinary steroids suggests that in some cases the defect is not an isolated deficiency of the C-2l enzyme but a more complex one involving both C-2l and C-ll hydroxylases.
The virilism is presumably due to the excessive production of 17-ketosteroids though it has been claimed but not substantiated that 17hydroxyprogesterone itself has androgenic effects.
The Norymberski method for ketogenic steroids normally measures hydrocortisone and its metabolites. The reaction involves the dihydroxyacetone and triol side chains characteristic of these compounds. It is important to realise that the glycol side chain of pregnanetriol is also oxidised by sodium bismuthate : high ketogenic steroid values in C.A.H. thus indicate the presence of a steroid of unusual configuration and with a biological significance quite different from that of hydrocortisone.
As Dr. Komrower showed there are two variants, one with hypertension, the other with a salt-losing tendency, in addition to the virilisation. The first of these, a rare one, shows a different excretory pattern. Urine pregnanetriol is increased to a lesser extent than in the uncomplicated condition; the important urinary steroids are compound S and its metabolites, which contain a dihydroxyacetone side chain but are not oxygenated at Col I. Compound S is less powerful than hydrocortisone in inhibiting pituitary ACTH release so we have a sequence of events similar to that described above. The deficiency in 11hydroxylase apparently leads to the synthesis of deoxycorticosterone since its tetrahydroderivative has been found in the urine in these cases. The hypertension is presumably due to this steroid.
Both the hypertension and virilism are reversible during treatment with cortisone.
In the second, salt-losing, variant, virilism, whilst associated with the usual evidence of intense adrenal biosynthetic activity, is also accompanied by evidence of adrenal failure. Episodes of collapse and dehydration occur, with low serum sodium and raised serum potassium. These latter are not due to inadequate synthesis of aldosterone. Urinary aldosterone may be normal or even elevated during periods of salt loss. Furthermore, urine electrolyte abnormalities seem to be directly correlated with the degree of adrenal activity, i.e., salt loss is increased during periods of stress and during the administration of ACTH. This has led to the suggestion that the adrenal might produce a salt-losing hormone which antagonises the influence of aldosterone on the renal tubules. It is not specified whether such a hormone is a normal or an accidental adrenal secretion. Efforts to find it have failed. Recently 3beta, 16alpha-dihydroxyallopregnan-20-one has been isolated from these cases but despite earlier reports it has not been possible to demonstrate a salt-losing effect on administration to animals. Others have suggested these cases represent a more severe degree of enzyme deficiency, hut studies of hydrocortisone excretion rates have shown that though these are lower than in normal persons they are not lower than in non-saItlosers.
Treatment aims at preventing or arresting precocious skeletal and sexual development. The nature of these-they are slow and subject to observer error-makes it difficult to find reliable clues to the adequacy of treatment over short periods of time. Biochemical control is thus essential, but it is important to select adequate criteria. (1) Lowering of 17ketosteroid output to a value commensurate with the patient's true age leads to overtreatment, (2) Lowering of 17-ketosteroid output to a value commensurate with the patient's maturity assessed by bone age is probably satisfactory. Limitations arise from the difficulty of precise determination of the bone age (~2 years). (3) Elimination of all abnormal steroids from the urine seems to be the ideal solution. Though determination of I7-ketogenic steroids includes pregnanetriol, it also estimates a variable amount of dihydroxyacetones even in untreated cases. When treating with cortisone further confusion arises from the appearance in the urine of its metabolites. This criticism loses some of its strength when prednisone is used since the weight of hormone given is about 75 per cent less. Few people have used the more potent dexamethasone but this is so potent and the useful dose so small that its urinary metabolites could probably be ignored. The estimation of pregnanetriol either alone or with I7-hydroxypregnanolone would seem to aim directly at an evaluation of the abnormality. The suppression of these steroids to less than 1 mg. per day seems to produce the excellent clinical results one would expect since it represents the complete inhibition of abnormal steroid production.
